Shares of Eli Lilly (LLY) are soaring in Tuesday's trading session after the company raised its full-year guidance, driven by the surging demand for its...
are soaring in Tuesday's trading session after the company raised its full-year guidance, driven by the surging demand for its offerings. BMO Capital Markets BioPharma Equity Research Managing Director Evan Seigerman joins the Morning BriefAddressing the competitive landscape Seigerman says it's"unlikely that any competitors are going to be out there in the next couple of years.
Seigerman highlights that the company is becoming"more and more efficient," opening additional facilities to support the surging demand. However, he notes that demand is through the roof, making it challenging to keep up. The analyst adds that his price target for the company is $900, but the stock's performance will be"driven by how quickly they can ramp up supply because the demand is there.
Given their healthy growth prospects and attractive valuation, I am bullish on these three stocks ahead of the next bull run. The post 3 No-Brainer Stocks to Buy Before a Bull Run appeared first on The Motley Fool Canada.In this piece, we will take a look at the 13 best extremely profitable stocks to invest in. If you want to skip our overview of the current stock market news and what profitability entails, then you can skip ahead to 5 Best Extremely Profitable Stocks to Invest in.
Tony Robbins is an expert on building wealth, but he didn't get there overnight. He spent years working with and learning from some of the most successful investors of all time -- including hedge...The Canadian dollar edged up to a near three-week high against its U.S. counterpart on Monday as risk sentiment improved and ahead of monthly GDP data this week that could offer clues on the strength of the domestic economy. The loonie was trading 0.1% higher at 1.3656 to the U.S. dollar, or 73.
OTTAWA -Canada's economy likely weakened in the first quarter, data from Statistics Canada showed on Tuesday, bolstering expectations that the Canadian central bank would have more reason to cut interest rates in June. Canada's gross domestic product rose 0.2% in February, less than analysts' estimates, while growth in March likely remained muted, Statistics Canada said.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly's weight loss drug could help sleep apnea patientsShares of Eli Lilly (LLY) are slightly above their flatline Wednesday morning after the pharmaceutical giant announced positive results from a clinical trial...
Read more »
Eli Lilly, Novo Euphoria Risks Disappointing Investors, Goldman SaysThe weight loss drug frenzy that’s driven Eli Lilly & Co. and Novo Nordisk A/S to record peaks is raising the stakes for investors, according to Goldman Sachs Group Inc. analysts.
Read more »
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo NordiskThe latest GLP-1 drugs are starting to see proof of greater use beyond diabetes and obesity. How will it affect makers Novo Nordisk and Eli Lilly?
Read more »
Weight loss drugs and the many use cases in medical treatmentsNovo Nordisk's (NVO) Ozempic and Wegouvy and Eli Lilly's (LLY) Zepbound are the leading names in the latest GLP-1 weight loss drug cycle, a trend that has...
Read more »
Weight-loss drug shortage result of 'unprecedented demand'Certain doses of Eli Lilly's (LLY) GLP-1 weight loss drugs Zepbound and Mounjaro are facing a supply shortage, much like competitor Novo Nordisk's (NVO) own ...
Read more »
Chinese State-Backed Firm Weighs Buying Major Stake in GLP ChinaChinese state-owned investment company Guangdong Holdings Ltd. is considering making a potential bid for the China operations of logistics firm GLP Pte, people familiar with the matter said.
Read more »